Global head and neck cancer diagnostics market expected to reach over US $11 billion by 2019, says Technavio

Renewable energy

 

This new market analysis from Technavio segments the global head and neck cancer diagnostics market by different diagnostic methods such as diagnostic imaging, endoscopy, and dental diagnostics. Additionally, the market is classified into different geographies, including the Americas, EMEA, and the APAC region, and discusses the trending factors influencing their market shares. GE Healthcare, Philips Healthcare, Siemens Healthcare, and Varian Medical Systems are the four leading vendors in the market. 

Technavio has released updated information on the cancer market, with the publication of its new market research report, global head and neck cancer diagnostics market. The global head and neck cancer diagnostics market is expected to grow at a CAGR of 13% between 2015 and 2019, owing to rising number of diagnostic procedures for pharyngeal and oral cancers. The Americas is the leading revenue generator in the global head and neck cancer diagnostics market. One of the main reasons for this region’s market growth is the increased prevalence of chronic diseases, especially head and neck cancers, among the aging population.

“Emergence of advanced molecular diagnostic devices has improved the detection and traetment of cancer. Increased adoption of nanotechnology has augmented the use of advanced X-ray and CT scan devices. Nanotechnology-based detectors and scanners use radiocontrast agents and iodinated contrast agents to enhance the examination technique. This technology is also used to detect and examine cancerous tumors. Researchers have also come up with HD endoscopes and dental radiographs for accurate diagnostic imaging,” says Imran Mushtaq, Lead Analyst, Healthcare & Lifesciences, Technavio Research.

Physicians across the globe are focusing on early diagnosis and treatment of chronic diseases. Early diagnosis of head and neck cancers can increase patient survival rate by about five years. Doctors are emphasizing on the follow-up programs like early detection and endoscopy to the affected individuals Healthcare facilities are also using endoscopies for screening the upper aero-digestive tract for tumors. Physicians perform biopsies to obtain directly tissue samples from the tumor or lymph node for cancer diagnosis and examination.

The leading vendors in the global head and neck cancer diagnostics market are GE Healthcare, Philips Healthcare, Siemens Healthcare, and Varian Medical Systems. The market is highly fragmented with the presence of a vast number of extremely competitive large and small vendors.

A more detailed analysis is available in the Technavio report, Global Head and Neck Cancer Diagnostics Market 2015-2019.

We can customize this reports by other regions and specific segments upon request.

Other Related Reports:

Further Reading: